Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Galera Therapeutics Inc

Current price
0.2 USD -0.008 USD (-3.77%)
Last closed 0.2 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 10 660 871 USD
Yield for 12 month -93.25 %
21.11.2021 - 28.11.2021

Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania. Address: P.O. Box 134, Malvern, PA, United States, 19355

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

0.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+88 000 USD

Current Year

-259 000 USD

Last Year

-114 000 USD

Current Quarter

-9 000 USD

Last Quarter

-127 000 USD

Key Figures GRTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -37 399 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -59.29 %
PEG Ratio
Return On Equity TTM -1063.11 %
Wall Street Target Price 0.5 USD
Revenue TTM
Book Value -2.48 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.91 USD
Diluted Eps TTM -0.91 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GRTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GRTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GRTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.1763
Price Book MRQ 29.3902

Financials GRTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GRTX

For 52 weeks

0.085 USD 3.59 USD
50 Day MA 0.19 USD
Shares Short Prior Month 2 793 016
200 Day MA 0.18 USD
Short Ratio 1.16
Shares Short 2 123 783
Short Percent 5.28 %

Dynamics of changes in the value of assets




430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds



14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics